Company Profile for Prevendia, Inc.

(BUSINESS WIRE)--Prevendia Inc. is an innovative medical diagnostic company offering a revolutionary solution to determine a patient’s insulin resistance (IR) level by analyzing a small blood sample and reporting the results. This testing is significant because IR is a silent condition that is an early predictor of serious chronic diseases such as type 2 diabetes (T2D) and cardiovascular disease (CVD). Additionally, clinical studies implicate IR as a precursor to infertility, obesity, sub-clinical inflammation, micro-vascular disease, hypertension, certain cancers and Alzheimer’s disease. When diagnosed, IR progression can be slowed, stopped or reversed by appropriate insulin sensitizing interventions. Prevendia’s clinical diagnostic solution is ideal for prenatal care, pediatrics, cardiovascular, infertility and corporate wellness programs.